A phase I/II study to assess the safety, tolerability and pharmacokinetics (PK) of intravenous (IV) infusion of MB07133 in subjects with unresectable hepatocellular carcinoma (HCC)
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: B. Ma, W. Forbes, A. P. Venook, D. M. Bissell, C. Peterson, I. Niculae, D. Bullough
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W89911354